MedPath

Influence of Air Pollution on SPondyloarthritis Flare-ups and Resistance to Treatment

Not yet recruiting
Conditions
Spondyloarthritis, Axial
Interventions
Other: Assessment of exposure to air pollution
Registration Number
NCT06077604
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The relationship between exposure to air pollution and spondyloarthritis (SpA) has been poorly studied. Based on data from the literature on other inflammatory pathologies such as rheumatoid arthritis, we hypothesize that there is a relationship between exposure to air pollution and the risk of presenting a flare-up in SpA patients following and living in Franche-Comté (France).

Primary objective:The potential relationship between exposure to air pollution (nitrogen dioxide, fine particles with a diameter of less than 10 or 2.5 microns and Ozone) and the onset of a spondyloarthritis flare-up will be explored in patients with this pathology.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
175
Inclusion Criteria
  • Diagnosis of Axial Spondyloarthritis (radiographic or non-radiographic) according to Assessment of SpondyloArthritis international Society (ASAS) criteria
  • Patient having received a consultation / hospitalization during the period 2019-2022
  • Patient enrolled in the MISTIC cohort
  • Having lived in Franche-Comté during the 2019-2022 period.
Exclusion Criteria
  • Other chronic inflammatory rheumatism (rheumatoid arthritis according to ACR 2010 criteria or psoriatic arthritis according to ClASsification criteria for Psoriatic ARthritis criteria)
  • No inflammatory rheumatic disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with a diagnosis of Axial SpondyloarthritisAssessment of exposure to air pollutionPatients with a diagnosis of Axial Spondyloarthritis, received in rheumatology consultation/hospitalization over the period 2019-2022 and living in Franche-Comté over the same period
Primary Outcome Measures
NameTimeMethod
Occurrence of a SpA flare-up6 to 24 months

The occurrence of a SpA flare-up measured by disease activity, defined according to the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) and/or ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score - C reactive protein) scores (BASDAI score ≥4/10 and/or ASDAS-CRP score ≥2.1) according to ASAS group

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Besançon University Hospital

🇫🇷

Besançon, Bourgogne Franche Comté, France

© Copyright 2025. All Rights Reserved by MedPath